Malignant Brain Tumors
9
2
4
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG
PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study
A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors
Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation
Expert Consensus and Artificial Intelligence in Medical Decision Making in Patients with Malignant Brain Tumors
(68^Ga)-GaPSMA-11 PET/MR-imaging of Malignant Intra-axial Brain Tumors
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Brain Tumors
PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors